Sign Up to like & get
recommendations!
1
Published in 2018 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2018.04.014
Abstract: PURPOSE Nemonoxacin, a nonfluorinated quinolone, has been approved in Taiwan and mainland China for the treatment of bacterial infection. Whether nemonoxacin is associated with the adverse events of other quinolones, such as the risk for…
read more here.
Keywords:
qtc;
qtc interval;
effects nemonoxacin;
study ... See more keywords